Trial
NCT00500240
Effect of Tight Control of Blood Glucose During Hyper-CVAD Chemotherapy For Acute Lymphocytic Leukemia (ALL)
Phase IIITERMINATEDEFFICACY/FUTILITYConfidence: HIGH
Sponsor
M.D. Anderson Cancer Center
Collaborators
Novo Nordisk A/S
Condition
Leukemia
Intervention
Insulin Glargine
Why stopped
Terminated early due to futility.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-06-03